Sponsor:
Trogenix ltd
Code:
NCT07346144
Conditions
Glioblastoma (GBM)
High Grade Gliomas
Recurrent Glioblastoma
Newly Diagnosed Glioblastoma
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
TGX-007
Valaciclovir
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-05. This information was provided to ClinicalTrials.gov by Trogenix ltd on 2026-06-12.